Cargando…

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study

Introduction Red cell distribution width (RDW) is associated with cardiovascular diseases, including atrial fibrillation (AF) and venous thromboembolism (VTE). Whether RDW is a risk marker for thromboembolic events in AF patients is scarcely known. We aimed to assess the association between RDW and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hald, Erin M., Løchen, Maja-Lisa, Lappegård, Jostein, Ellingsen, Trygve S., Mathiesen, Ellisiv B., Wilsgaard, Tom, Njølstad, Inger, Brækkan, Sigrid K., Hansen, John-Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521943/ https://www.ncbi.nlm.nih.gov/pubmed/33005859 http://dx.doi.org/10.1055/s-0040-1716417

Ejemplares similares

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study
por: Lappegård, Jostein, et al.
Publicado: (2018)

Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study
por: Skjelbakken, Tove, et al.
Publicado: (2014)

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
por: Ellingsen, Trygve S., et al.
Publicado: (2018)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2014)

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study
por: Rinde, Ludvig B., et al.
Publicado: (2016)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2020)

Association of occasional smoking with total mortality in the population-based Tromsø study, 2001–2015
por: Løchen, Maja-Lisa, et al.
Publicado: (2017)

Cohort profile: The Tromsø Study
por: Jacobsen, Bjarne K, et al.
Publicado: (2012)

Atrial Fibrillation and Cause‐Specific Risks of Pulmonary Embolism and Ischemic Stroke
por: Hald, Erin M., et al.
Publicado: (2018)

Data from national health registers as endpoints for the Tromsø Study: Correctness and completeness of stroke diagnoses
por: Varmdal, Torunn, et al.
Publicado: (2021)

Cardiovascular health and the modifiable burden of incident myocardial infarction: the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2015)

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study
por: Lind, Caroline, et al.
Publicado: (2017)

Sex-Specific Associations between Blood Pressure and Risk of Atrial Fibrillation Subtypes in the Tromsø Study
por: Espnes, Hilde, et al.
Publicado: (2021)

Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012
por: Carlsson, Maria, et al.
Publicado: (2016)

Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study
por: Solomon, Terry, et al.
Publicado: (2016)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study—the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2020)

The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study
por: Jorde, Rolf, et al.
Publicado: (2015)

Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Tromsø Study 1994–2016
por: Hopstock, Laila A, et al.
Publicado: (2018)

Validating Acute Myocardial Infarction Diagnoses in National Health Registers for Use as Endpoint in Research: The Tromsø Study
por: Varmdal, Torunn, et al.
Publicado: (2021)

Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
por: Zostautiene, Ieva, et al.
Publicado: (2015)

Correction: Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
por: Martinaityte, Ieva, et al.
Publicado: (2016)

Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905–1977 in the population-based Tromsø Study 1979–2016
por: Hopstock, Laila Arnesdatter, et al.
Publicado: (2017)

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
por: Johnsen, Stein Harald, et al.
Publicado: (2018)

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
por: Tiwari, Sweta, et al.
Publicado: (2015)

Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population‐Based Tromsø Study
por: Ball, Jocasta, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromsø Study
por: Jorde, Rolf, et al.
Publicado: (2012)

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study
por: Horvei, Lars Daae, et al.
Publicado: (2016)

Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromsø study
por: Hagen, Amalie Nilsen, et al.
Publicado: (2022)

Low Pain Tolerance Is Associated With Coronary Angiography, Coronary Artery Disease, and Mortality: The Tromsø Study
por: Fladseth, Kristina, et al.
Publicado: (2021)

Lipid Levels During Adult Lifetime in Men and Women With and Without a Subsequent Incident Myocardial Infarction: A Longitudinal Analysis of Data From the Tromsø Study 1974 to 2016
por: Albrektsen, Grethe, et al.
Publicado: (2023)

Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study
por: Sharashova, Ekaterina, et al.
Publicado: (2020)

Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
por: Nilsen, Amalie, et al.
Publicado: (2021)

Data on gender contrasts in the risk of incident myocardial infarction by age. The Tromsø Study 1979–2012
por: Albrektsen, Grethe, et al.
Publicado: (2017)

Prevalence of general and abdominal obesity in 2015–2016 and 8-year longitudinal weight and waist circumference changes in adults and elderly: the Tromsø Study
por: Løvsletten, Ola, et al.
Publicado: (2020)

Hand grip strength and risk of incident venous thromboembolism: The Tromsø study
por: Leknessund, Oda G. R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_og7nu0vb95se26jimrm76162k8